Why the study?
Does long-term oral anticoagulation reduce total deaths and/or major thromboembolic events in adults with heart failure?
Does long-term oral anticoagulation reduce total deaths and/or major thromboembolic events in adults with heart failure?
Current evidence does not support the routine use of oral anticoagulation in heart failure patients in sinus rhythm.
No takes yet. Share an insight, caveat, or question.
Does not support routine anticoagulation in sinus-rhythm HF; leaves open benefit in contemporary RCTs.
Gregory Y.H. Lip (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: